In recent years IDL Biotech has been working on developing a rapid test to detect lung cancer, under the project name MonoTotal® Rapid. However, further development will instead focus on creating a rapid test for breast cancer.
Read the article here (Swedish)
A delegation from Airlangga University and Dr. Soetomo General Hospital visited the AroCell/IDL Biotech office in Stockholm on Tuesday, 18th of June. The Indonesian Embassy in Sweden facilitated the meeting. Airlangga University, one of the oldest medical schools in...
Last week AroCell participated in three major events across the medical and research domains. From Paris to San Diego and Copenhagen, our team presented the latest advancements and interacted with industry and scientific leaders in the field. EAU Congress 2024 In...
A recent study investigated the use of urine-based biomarkers, including UBC Rapid, to monitor high-risk non-muscle invasive bladder cancer patients. The purpose of the study was to discover new applications for these biomarkers in order to safely reduce the frequency...
